Autologous Bone Marrow-Derived Stem Cell Therapy in Combination with TMLR. A Novel Therapeutic Option for Endstage Coronary Heart Disease: Report on 2 Cases
- 1 October 2004
- journal article
- case report
- Published by Forum Multimedia Publishing LLC in The Heart Surgery Forum
- Vol. 7 (5) , E416-E419
- https://doi.org/10.1532/hsf98.20041095
Abstract
Metapress is the fastest-growing resource of expert content online -- Discover more about what interests you, learn new skills, and find inspiration.Keywords
This publication has 14 references indexed in Scilit:
- Myoendothelial Differentiation of Human Umbilical Cord Blood–Derived Stem Cells in Ischemic Limb TissuesCirculation Research, 2003
- Autologous bone-marrow stem-cell transplantation for myocardial regenerationThe Lancet, 2003
- The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine heartsEuropean Journal of Cardio-Thoracic Surgery, 2002
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Differentiation and expansion of endothelial cells from human bone marrow CD133+ cellsBritish Journal of Haematology, 2001
- Myoblast transplantation for heart failureThe Lancet, 2001
- Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory AnginaNew England Journal of Medicine, 1999
- Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Histological Findings After Transmyocardial Laser RevascularizationJournal of Cardiac Surgery, 1996